Bilateral Vestibular Hypofunction in Neurosarcoidosis: A Case Report by Smith, Jonathan H. et al.
Barrow Neurological Institute at St. Joseph's Hospital and Medical Center 
Barrow - St. Joseph's Scholarly Commons 
Neurology Articles Neurology 
2011 
Bilateral Vestibular Hypofunction in Neurosarcoidosis: A Case 
Report 
Jonathan H. Smith 
Kyndra C. Stovall 
Stephen W Coons 
stephen.coons@dignityhealth.org 
Terry D. Fife 
Barrow Neurological Institute, tfife@email.arizona.edu 
Follow this and additional works at: https://scholar.barrowneuro.org/neurology 
Recommended Citation 
Smith, Jonathan H.; Stovall, Kyndra C.; Coons, Stephen W; and Fife, Terry D., "Bilateral Vestibular 
Hypofunction in Neurosarcoidosis: A Case Report" (2011). Neurology Articles. 56. 
https://scholar.barrowneuro.org/neurology/56 
This Article is brought to you for free and open access by the Neurology at Barrow - St. Joseph's Scholarly 
Commons. It has been accepted for inclusion in Neurology Articles by an authorized administrator of Barrow - St. 
Joseph's Scholarly Commons. For more information, please contact molly.harrington@dignityhealth.org, 
andrew.wachtel@dignityhealth.org. 
Volume 90, Number 1  www.entjournal.com ■ E1
BILATERAL VESTIBULAR HYPOFUNCTION IN NEUROSARCOIDOSIS: A CASE REPORT SMITH, STOVALL, COONS, FIFE
Bilateral vestibular hypofunction in 
neurosarcoidosis: A case report  
ONLINE EXCLUSIVE
Jonathan H. Smith, MD; Kyndra C. Stovall, PhD; Stephen Coons, MD; 
Terry Douglas Fife, MD 
From the Department of Neurology, Mayo Clinic, Rochester, Minn. (Dr. 
Smith); the College of Pharmacy, University of Georgia, Athens (Dr. 
Stovall); and the Barrow Neurological Institute, University of Arizona 
College of Medicine, Phoenix (Dr. Coons and Dr. Fife). 
Corresponding author: Terry Douglas Fife, MD, Barrow Neurological 
Institute, 240 W. Thomas Rd., Suite 301, Phoenix, AZ 85013. E-mail: 
tfi fe@email.arizona.edu 
Abstract 
We describe the case of a 59-year-old woman who presented 
with progressive bilateral vestibular hypofunction and who 
was found to have bilateral granulomatous mass lesions 
of the mesial temporal lobe. Initially, her condition stabi-
lized neurologically with corticosteroids, but a diagnosis 
of neurosarcoidosis was delayed because of the unusual 
presentation and persistently normal chest imaging results 
and serum angiotensin-converting enzyme (ACE) levels. 
Approximately 1 year after her initial presentation, the 
patient died of complications of a myocardial infarction and 
pulmonary embolism. Sarcoidosis should be considered in 
the differential diagnosis of idiopathic bilateral vestibular 
hypofunction even if the chest imaging and serum ACE 
levels are normal, particularly when there is evidence of 
a multisystem process. 
Introduction 
Sarcoidosis is a chronic multisystem granulomatous 
disorder of unclear etiology. Pathologically, it features 
diseased tissue that is characterized by the presence of 
epithelioid, noncaseating granulomas. Neurosarcoi-
dosis is a rare manifestation of this disease, clinically 
affecting only 5% of all patients with sarcoidosis.1 The 
most common neurologic feature of neurosarcoidosis 
is cranial neuropathy, which is attributable to frequent 
granulomatous involvement of the basal leptomeninges. 
Parenchymatous disease may also occur, most often in 
the hypothalamus and the pituitary gland.2 
Audiovestibular dysfunction in neurosarcoidosis is 
rare. In an extensive review of neurosarcoidosis case 
reports, Colvin found that 28 of 31 patients (90%) for 
whom audiometric data were available had experienced 
either a sudden or rapidly progressive hearing loss.3 
Among 24 patients who had undergone vestibular 
function testing, 23 had abnormal results; of these 23, 
6 had unilateral and 16 had bilateral loss of vestibular 
function (the remaining patient’s study was nonlocal-
izing). Vestibular impairment in the absence of hearing 
loss may also occur.4 
In this article, we describe an unusual case of neu-
rosarcoidosis that featured the rare manifestation of 
bilateral vestibular dysfunction in the absence of audi-
tory impairment. 
Case report 
A 59-year-old woman presented with a 4-month history 
of progressive gait imbalance without vertigo. Exami-
nation showed a widened gait base and poor balance. 
Hearing, speech, articulation, and vision were normal. 
Magnetic resonance imaging (MRI) of the brain dem-
onstrated an increased signal on gadolinium-enhanced 
T1-weighted imaging in the mesial right temporal lobe 
and minimal change in the left temporal lobe (fi gure 
1, A). A diagnosis of herpes simplex encephalitis was 
entertained along with other infectious, infl ammatory, 
and neoplastic etiologies. Cerebrospinal fl uid (CSF) 
studies revealed 14 white blood cells/µl, which were 
100% lymphocytes; a CSF glucose level of 57 mg/dl; 
and a CSF protein concentration of 52 mg/dl. Bacterial 
and fungal cultures were negative, as was a polymerase 
chain reaction assay for herpes simplex in CSF. In ad-
dition, fi ndings on CSF VDRL testing, coccidioides 
serology, cerebral angiography, and chest x-ray were all 
normal. Electroencephalography (EEG) showed bitem-
poral slowing, but no epileptiform changes. The serum 
angiotensin-converting enzyme (ACE) level (17 U/L) 
and serum calcium concentration (9.7 mg/dl) were both 
within normal limits. A purifi ed protein derivative of a 
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tuberculin skin test was nega-
tive, but the patient was anergic 
to mumps. 
An excisional biopsy of the 
right temporal lobe revealed 
lymphoplasmacytic infl amma-
tion with noncaseating granulo-
mas, clusters of fi broblasts and 
histiocytes, and multinucleated 
giant cells (fi gure 2). No cultures 
grew from the specimen. Anti-
microbial therapy was given em-
pirically; it included ceftriaxone, 
acyclovir, isoniazid, rifampin, 
ethambutol, and pyrazinamide. 
The patient was also started on dexamethasone at 8 mg 
twice daily. 
At a follow-up appointment 2 months later, the 
patient had shown some improvement in her balance, 
and a repeat MRI demonstrated a partial resolution 
of the right temporal lesion. The decision was made 
to taper the steroids and continue the antimicrobial 
therapy. However, 2 weeks later (and 7 months after 
her initial onset of imbalance), the patient returned 
with complaints of acute amnesia and confusion. She 
said she woke up feeling that she had “lost one and a 
half years” of memory. On examination, her attention 
and registration were good, but her recall was poor. She 
was completely unaware of the events that had led to 
her current health situation. She exhibited delusional 
thinking at times. Prior to her current situation, she 
had no history of behavioral change or cognitive defi cit. 
Her dizziness had also progressed to the point where 
she felt unable to sit up. A repeat MRI demonstrated 
signifi cant progression of the left temporal lesion and 
a slight enlargement of the area of signal change in the 
hippocampal area on the right side (fi gure 1, B). Repeat 
EEG monitoring revealed generalized slowing and no 
seizures, but phenytoin was started empirically. Com-
puted tomography (CT) scans of the chest, abdomen, 
and pelvis were negative. A gallium scan demonstrated 
focal uptake in the hila of both lungs consistent with 
sarcoidosis, which had not been evident on chest x-ray 
and chest CT. The patient was stabilized neurologically 
with methylprednisolone at 1,000 mg/day for 5 days. She 
was discharged on prednisone at 60 mg/day. 
On outpatient follow-up, rotational and caloric 
vestibular testing demonstrated severe bilateral loss of 
peripheral vestibular function. The patient’s hearing 
remained intact, and no uveitis or periocular sarcoidosis 
was observed. Five months later, she died from com-
plications of a myocardial infarction and pulmonary 
embolism. 
Discussion 
In this case, the initial complaint was of imbalance, 
which was most likely caused by the progressive bilateral 
vestibular dysfunction. Bilateral vestibular hypofunction 
may present without nystagmus, nausea, or vertigo, par-
ticularly if the loss of function occurs symmetrically or 
gradually. Sakakibara et al reported a case of vestibular 
dysfunction that produced progressive ataxia, but that 
case also featured some element of communicating 
hydrocephalus that might have contributed to the 
ataxia.5 
Loss of vestibular function has been reported both 
with5-10 and without4 hearing loss. Hearing loss secondary 
to sarcoidosis is often bilateral and frequently associated 
with fl uctuating hearing. In an extensive review of the 
literature, Mende and Suchenwirth found hearing loss in 
12.2% of patients with neurosarcoidosis and nystagmus 
in 8.6%.11 On the other hand, Hybels and Rice found 
audiovestibular dysfunction to be more common.12 
Colvin’s review of 48 case reports and 2 additional cases 
found normal hearing in only 1 of 22 patients for whom 
pure-tone audiometric data were available, suggesting 
that vestibular loss with spared hearing is quite rare 
among patients with neurosarcoidosis.3 
Sarcoidosis-related vestibular dysfunction may occur 
as a result of vasculitis or granulomatous infl amma-
tion of the vestibulocochlear nerves4,7 and perhaps by 
direct labyrinthine involvement.13 Auditory impairment 
may be caused by granulomatous infl ammation of the 
arachnoid vessels, the cochlear nuclei, vestibulocochlear 
nerves, or the labyrinth itself.10 Von Brevern et al found 
Figure 1. A: Coronal T1-weighted MRI 4 months after the onset of symptoms shows gadolinium 
enhancement of the mesial temporal lobe lesions. B: A similar view at 7 months shows postopera-
tive changes in the right temporal lobe. 
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paroxysmal positional verti-
cal nystagmus with absent 
horizontal canal vestibular 
responses.4 They suggested 
that selective vestibular dys-
function may result from fo-
cal vasculitis. In a case report 
by Babin et al, temporal bone 
histology in a patient with 
deafness showed prominent 
perivascular lymphocytic in-
fi ltration with degeneration 
of nerve axons and myelin.14 
The authors hypothesized 
that sarcoidosis in this area 
begins as a reversible neuropathy and evolves over time 
to an irreversible degeneration of neuroepithelium and 
nerve elements. In our patient, vestibular function never 
returned, although it is possible that corticosteroids 
had been administered too late in the clinical course to 
induce a recovery. 
Parenchymal mass lesions have been seen in neurosar-
coidosis, and they may mimic gliomas or lymphoma.15 
Our patient developed both an anterograde and tem-
porally graded retrograde amnesia that was clinically 
and radiographically consistent with the syndrome of 
bitemporal amnesia.16 A normal chest x-ray, chest CT, 
and serum ACE level do not exclude the possibility of 
neurosarcoidosis.17,18 A tissue biopsy may be the only 
means of making the diagnosis in such instances.19 
A gallium scan20 or whole-body positron-emission 
tomography17,21 may also help with the diagnosis if 
changes are seen in the pulmonary hila or salivary glands, 
and such imaging may direct the location for a biopsy. 
Corticosteroids may be used empirically but with cau-
tion, and every attempt should be made to confi rm a 
diagnosis because some neurologic manifestations of 
sarcoidosis may fail to improve with steroids and require 
more aggressive immunomodulating drugs.22 
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Figure 2. A: The histologic section from the right temporal lobe biopsy demonstrates non-necrotizing 
granulomatous infl ammation consisting of nodular foci of numerous histiocytes, lymphocytes, and 
plasma cells. A multinucleated giant cell (MNGC) is also seen (DAB and hematoxylin, original mag-
nifi cation ×100). B: At higher power, a noncaseating granuloma (arrows) demonstrates mononuclear 
histiocytes admixed with an MNGC (DAB and hematoxylin, original magnifi cation ×400). 
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